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Abstract
Background: The SELPHI study (An HIV Self-Testing Public Health Intervention) is an online randomised controlled
trial (RCT) of HIV self-testing (HIVST). The aim of this study was to assess the feasibility of recruiting UK men who
have sex with men (cis and trans) and trans women who have sex with men to the SELPHI pilot, and the
acceptability of the HIVST intervention used among those randomised to receive a kit.
Methods: A mixed-methods approach to assessing trial feasibility and intervention acceptability was taken, using
quantitative data from advertising sources and RCT surveys alongside qualitative data from a nested sub-study.
Results: Online recruitment and intervention delivery was feasible. The recruitment strategy led to the registration
of 1370 participants of whom 76% (1035) successfully enrolled and were randomised 60/40 to baseline testing vs
no baseline testing. Advertising platforms performed variably. Reported HIVST kit use increased from 83% at
two weeks to 96% at three months. Acceptability was very high across all quantitative measures. Participants
described the instructions as easy to use, and the testing process as simple. The support structures in SELPHI were
felt to be adequate. Described emotional responses to HIVST varied.
Conclusions: Recruiting to a modest sized HIVST pilot RCT is feasible, and the recruitment, intervention and HIVST
kit were acceptable. Research on support needs of individuals with reactive results is warranted.
Keywords: HIV self-testing, Men who have sex with men, Transgender people, Randomised controlled trial, Online
service delivery, Implementation science, Process evaluation
Background
Late diagnosis of HIV infection and on-going HIV transmis-
sion in UK men who have sex with men (MSM) and trans-
gender people are enduring public health challenges [1, 2].
Despite recent successes in reducing HIV incidence through
combination prevention initiatives including expansion of
testing, many MSM continue to test sub-optimally and up
to 25% have never tested [1, 3–5]. Few data exist on HIV
testing among transgender people, although transgender
women are disproportionately affected by HIV [6, 7] and
evidence suggests innovative HIV prevention interventions
are key to reducing incidence in this group [7].
HIV self-testing (HIVST) is a recent approach whereby
an individual tests themselves and reads their own result
using a rapid diagnostic test. There is an emerging evi-
dence base suggesting that HIVST has the potential to
improve access and overcome barriers to testing through
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reducing stigma and privacy concerns as well as increas-
ing convenience and ameliorating geographical barriers
in areas underserved by other HIV testing opportunities
[8, 9]. It also provides flexibility in intervention design:
components and delivery mechanisms can be adapted
depending on the target population [8]. In 2016 the
World Health Organization incorporated HIVST into its
Consolidated Guidelines for HIV Testing Services with
the recommendation that HIVST be provided as a sup-
plementary option alongside existing services [10].
Evidence from UK studies conducted shortly after
HIVST became commercially available in 2015 suggests
that HIVST is acceptable, and that MSM have prefer-
ences for blood-based tests (due to perceptions of
greater accuracy) and easy access to confirmatory testing
[5, 11, 12]. However, a minority of MSM with aversion
to blood reported being unwilling to use a blood-based
kit [11]. Home delivery of an HIVST kit is a barrier for
some with concerns around domestic privacy [11].
HIVST may be more appealing to groups who do not test
in line with current guidelines, which recommend annual
testing for all MSM, or more frequent testing if at in-
creased risk [5]. Evidence also suggests that challenges re-
lating to instructions and lack of familiarity with testing
procedures may present barriers to use, particularly ini-
tially [11]. Little data exists on trans populations, although
a study in San Francisco found HIVST was acceptable and
feasible for trans women [13]. In addition, a small number
of trans women have accessed England’s national HIV
self-sampling (HIVSS) service indicating that testing out-
side clinics may be preferable to some [2].
HIVSS, whereby a person takes their own sample and
returns it to a lab that then processes it and provides a re-
sult, is the technology perhaps most analogous to HIVST.
HIVSS has suffered from sub-optimal sample returns,
with testing completion rates around 55% in service evalua-
tions in the UK [14, 15]. Evidence suggests this relates to
complicated sampling procedures which are not always feas-
ible or acceptable to the target populations, including taking
a sufficiently large blood sample to facilitate testing [16, 17].
If those accessing HIVST face similar barriers in performing
tests this could threaten the aspiration of increasing test-
ing uptake and frequency through the provision of this novel
technology. Further, although the expansion of commercially
available HIVST has seen moderate levels of uptake in the
USA [18], HIVST may fulfil different roles for populations
such as in the UK where HIV testing services are very well
developed. This is especially true should HIVST also be pro-
vided at no cost, as with the vast majority of existing HIV
testing models in the UK.
The SELPHI study (An HIV Self-Testing Public Health
Intervention) is an online randomised controlled trial
(RCT) being conducted between 2017 and 2020 which
aims to assess whether HIVST can; (i) increase rates of
diagnosis in those with prevalent HIV infection and ii) re-
duce the time between infection and diagnosis for those at
risk of incident infection. The primary outcomes are
ascertained through linkage to the national HV surveil-
lance systems indicating confirmatory testing and linkage
to care. SELPHI aimed to recruit 10,000 MSM (cis and
trans) and trans women. Participants were recruited
through advertising on geo-location social-sexual network-
ing applications and Facebook. Initial baseline randomisa-
tion was to an offer of postal delivery of an HIVST kit
accompanied with a follow-up survey or to no HIVST.
Intervention conceptualisation was underpinned by
the COM-B model of behaviour change [19, 20]. COM-
B is a systematically developed model which consolidates
19 pre-existing frameworks, positing that alterations in
capability, opportunity and motivation are key to suc-
cessful behaviour change interventions [20]. This model
was chosen because of its simplicity and flexibility, and
because of its use in HIV prevention interventions as
well as interventions which include the provision of
technologically assisted behaviour change [21–26]. The
pilot phase of SELPHI ran from February to May 2017
and aimed for 1,000 recruits, from the overall target of
10,000.
Evidence on HIVST intervention implementation feasi-
bility and acceptability in high income settings to date has
focused on small scale demonstration studies distributing
small numbers of kits with limited follow-up [27, 28]. The
SELPHI pilot provides an opportunity to generate evidence
about whether large-scale implementation of an online
HIVST RCT is feasible in high-income settings. Usability of
HIVST, defined as “the extent to which a product can be
used by specified users to achieve specified goals with ef-
fectiveness, efficiency and satisfaction in a specified context
of use [29]”, can also be assessed. It is also vital to under-
stand intervention acceptability among those who receive
the intervention to inform practitioners, policy makers and
commissioners. This study, which is grounded in imple-
mentation science, will be useful in a range of contexts with
similar health system features and HIV epidemics.
The aim of this study is therefore to assess the feasibility
of recruiting to an online HIVST RCT in which partici-
pants are randomised to receive a free kit or not, and the
acceptability of the HIVST intervention used among those
randomised to receive it. We consider key questions re-
lated to advertising performance, reach, uptake, kit usabil-
ity and end user reception. We use a mixed methods
approach examining the feasibility of recruitment, the mo-
tivations of SELPHI participants, and the usability and ac-
ceptability of the kit itself. Theoretically, this work is
informed by COM-B, a behaviour change model which is
often used to explore acceptability and to conceptualise
intervention components and how they may work to-
gether to produce behaviour change [20, 22, 30, 31].
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Methods
This mixed-methods study follows a data integration ap-
proach termed by Moran-Ellis et al. as following a thread
[32]. As such key areas of inquiry were identified from
quantitative RCT data; these were then used to guide
the focus of the analysis of the in-depth interviews. This
has allowed us to generate additional nuance in respond-
ing to questions about feasibility and acceptability.
RCT study procedures
The pilot was designed to test the RCT recruitment
strategy and the procedures in place for the full online
trial. The pilot also tested the likely acceptability of the
intervention, especially the usability of the chosen
HIVST kit, its delivery mechanisms and the support of-
fered for its use. Full details of the RCT methods can be
found in the published protocol [33].
Eligible participants were men (cis and trans) and
trans women; reporting lifetime anal sex with a man; not
known to be HIV positive; aged 16 years and older; resi-
dent in England or Wales; willing to provide name, date
of birth, postal and email address; consent to linkage
with surveillance and clinic databases and not previously
enrolled to the study.
The recruitment strategy utilised adverts placed in
geo-location social-sexual networking applications (apps)
(Grindr, Growlr, Scruff & Hornet) as well as targeted
Facebook advertising. Free advertisements were placed
on the Facebook page of a transgender focused clinical
service. Recruitment sources were chosen based on pre-
vious experience, and through consultation with volun-
tary sector organisations. Grindr was chosen as it has
the largest market share in the UK, with Hornet target-
ing a similar group. Growlr caters to a largely older sub-
group of MSM, while Scruff is ostensibly most used by
hirsute MSM and their admirers. Some adverts targeted
a national audience, while others took a city or regional
approach. Messaging was devised drawing learning from
earlier formative work [11, 34], and with participant and
public involvement (PPI) representatives. Key themes re-
garding barriers and facilitators to recruitment were
identified, and two members of the study team met with
PPI co-chairs to develop specific advertising messages.
Adverts focused on all COM-B domains: capability was
addressed through promoting ease of HIVST use; oppor-
tunity was addressed through highlighting the HIVST
kits were available at no cost; and motivation was
enhanced through highlighting privacy and appealing to
altruism to take part in a study. Some messages specif-
ically highlighted trans eligibility. Advertisements ap-
peared as sponsored posts, as direct inbox messages, as
pop-up messages and as banners.
Participants were directed to a registration survey re-
quiring informed consent and confirming eligibility, and
then to an enrolment survey via email. Ineligible partici-
pants (and those not randomised to HIVST) were offered
additional information on HIV testing. The enrolment
survey asked additional demographic and behavioural
questions. Participants were randomised 60:40 to receive
an HIVST kit (baseline test [BT]) or to no kit offer (no
baseline test [nBT]). Kits were distributed by post, directly
to the given address by the test manufacturer (BioSure™).
Two weeks after enrolment, participants randomised
to receive the HIVST kit were emailed an online follow-
up survey asking if the kit had been used (and if not,
why not), what the test result was, and whether further
care was accessed. Two reminders were sent.
Three months after randomisation a survey was emailed
to all participants asking for information on testing and
risk behaviour in the intervening period. Two reminders
were sent. Participants randomised to BT were also asked
questions about their experiences with HIVST. They
ranked on a 5-point scale their agreement with statements
related to acceptability and usability of the kit: 1) the in-
structions were easy to use; 2) performing the test was
simple; and 3) my overall experience was good.
Intervention development
The intervention being trialled was linear. The recruit-
ment messages being tested were both part of the inter-
vention and trial process, but in a scaled-up intervention
delivering HIVST these would be adapted accordingly. A
brief HIV risk assessment was conducted through behav-
ioural questions in the enrolment survey. The kit and
accompanying sleeve were then delivered and two weeks
later a follow-up survey asked about kit use and the test
result. Those who reported not receiving a kit had a new
delivery arranged. These components (advertisement,
risk assessment, kit and two-week follow-up) were de-
fined as the intervention as all were theorised to increase
engagement with HIV testing through COM-B channels.
Formative work was central to intervention develop-
ment. Focus groups with MSM and key informant inter-
views identified specific barriers to uptake and use of the
HIVST which the SELPHI intervention development was
attentive to ameliorating, using COM-B. These efforts
were also used in developing appropriate messaging for
advertising. Figure 1 provides a visualisation of interven-
tion components with a description of the intervention
functions and the COM-B domains they seek to affect.
Anticipated concerns regarding ease of use, coded in
COM-B as capability (physical), were addressed in
advertisements (see Fig. 2 for examples). This combined
intervention approaches described as persuasion and
education in COM-B [20], enhancing motivation by
minimising concerns regarding ease of use and
highlighting privacy and convenience. Issues concerning
lack of knowledge in using HIVST were also identified.
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The COM-B model codes this as psychological capabil-
ity; the behaviour change wheel then suggests interven-
tion functions such as education, training and
enablement might be useful [20]. This was alongside an
observed preference for additional supportive informa-
tion beyond what was provide in the original BioSure™
kit. This necessitated the development of a sleeve over
the box holding the kit to provide support information
(education), as well as behavioural support (enablement)
which was highlighted in the two-week follow-up survey.
The sleeve also provided signposting to a free telephone
helpline and website for HIV and sexual health informa-
tion (enablement).
In order to increase engagement with HIV testing gen-
erally, a risk assessment was included in the enrolment
survey to provide a reflective experience examining per-
sonal risk. It was theorised that this approach (persuasion)
can increase motivation (reflective and automatic) [20].
Formative research also identified issues with the in-
structions and packaging of an earlier iteration of the
kit, both of which reduced motivation to access HIVST
and capability when doing so. The kit instructions were
reformatted by the manufacturer before implementation
began, effectively addressing this issue. This intervention
component is theorised as training (the imparting of
skills) in the COM-B system [20].
The broader HIVST literature identifies support issues
as a key concern in HIVST delivery, a concern also iden-
tified in our formative work [8, 11, 35]. This informed
the provision of enhanced support information via our
kit sleeve produced in collaboration with our community
advisory group co-chairs (see Additional file 1). The
two-week follow-up survey was also designed to counter
this concern. If a participant reported a positive result
here, they were directed to a page providing information
on how to find their local HIV clinic. This same page
was linked to from the three-month survey. Additional
information about receiving a positive result was pro-
vided on the SELPHI website.
Data handling, generation & analysis
Data pertaining to advertising reach was recorded for all
adverts, then pooled according to platform. The click
conversion rate (proportion of those clicking on the ad-
vert who subsequently registered) was calculated. Eli-
gible and ineligible registrations as well as the number
of successful randomisations were tabulated. Registration
conversion was calculated by deriving the proportion of
eligible registrations who filled in the enrolment survey
and were subsequently randomised.
Baseline demographic and behavioural profiles were
tabulated overall and by recruitment source. Variables
considered were age (both continuous and 10 year
bands), gender, sexual orientation, ethnicity (recoded
from standard UK ethnicity codes into white, Asian,
black & other), highest educational qualification (low:
GCSEs and below; medium: A-levels or equivalent,
higher education below degree level; high: degree or
higher), HIV testing history (tested in preceding 12
months; tested more than 12months ago; never tested),
and condomless anal intercourse (CAI) in the preceding
3 months. Participant demographic and behavioural
characteristics were compared between recruitment
sources using chi-squared tests or a Kruskal-Wallis test
for age.
Responses to the 2-week survey were summarised by
proportion who completed the survey, proportion who
received the kit, and the proportion who subsequently
used the kit.
Kit use was summarised again from the 3-month sur-
vey alongside acceptability variables pertaining to in-
structions, simplicity of test performance and overall
experience.
Qualitative data
A qualitative study was undertaken with 10 cis-gender
MSM participants during the pilot in order to examine
intervention acceptability in greater depth. Participants
were sampled purposively from those randomised to
Fig. 1 Intervention diagram with COM-B categorisation and targeted domains
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receive an HIVST kit. Sampling aimed to be diverse
with regard to testing history: whether an individual
had tested in the 12 months before joining SELPHI;
not tested in the preceding 12 months; or never previ-
ously tested for HIV. Efforts were made to ensure sam-
ple diversity with regard to demographic features,
especially education.
A semi-structured interview topic guide was developed
to explore questions from formative research [11, 34], in-
cluding issues related to capability, HIVST potential, antici-
pated responses and acceptability and mapped onto COM-
B. The guide covered HIV testing history, motivations for
joining and experiences of the SELPHI RCT, questions re-
lated to using HIVST and emotional responses.
Interviews were conducted over the phone or through
Skype, and participants were electronically given a £30 in-
centive. All interviews were audio recorded and transcribed.
A thematic framework was developed for analysis, fus-
ing the approaches described by Braun and Clarke [36]
and Richie and Spencer [37]. This inductive process in-
volved familiarisation with the transcripts and drawing
out emerging themes. These themes were arranged into
groups, with higher-level themes emerging from sub-
themes, both organised hierarchically, and again mapped
onto COM-B to better elucidate how acceptability of
intervention components related to the behaviour change
domains. The framework was piloted on two transcripts,
refined, and applied to all remaining transcripts. We draw
data from across this framework and report themes by
COM-B domain for simplicity of interpretation.
Ethical approval for the RCT and qualitative sub-study
were provided by MRCCTU and LSHTM (refs: 11945 &
9233/001). SELPHI is registered with the ISRCTN (ref:
ISRCTN20312003). All RCT participants provided online
written consent. Qualitative sub-study participants pro-
vided verbal recorded consent at the time of interview.
Results
The recruitment strategy led to the registration of
1370 eligible participants through 13 advertisements
across 5 platforms, of whom 76% (1035) subsequently
enrolled and reached baseline randomisation. In this
pilot, 631 participants were randomised to receive an
HIVST kit (BT), while 404 were randomised to not
receive a kit (nBT). Of those randomised to BT, 66%
(415) completed the two-week follow-up survey and
64% (405) completed the first three-month survey.
Overall 78% (494/631) completed at least one of these
two surveys (2-weeks or 3-months).
Recruitment strategy performance
Click conversion was highly variable, from 8% in Grindr
adverts to 20% in Facebook advertising. Registration
conversion ranged from 71 to 80% (mean = 76%). Cost
per randomised participant varied: Hornet was cheapest
(£1.66) and Grindr most expensive (£7.16). Costs were
stable through this phase, with no evidence in the pilot
of diminishing returns. See Table 1 for full details.
Fig. 2 Advertising samples
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Demographic features of sample including by recruitment
source
Table 2 presents baseline demographics overall and by
recruitment source. Figure 3 presents the geographic
distribution of randomised participants with each dot
representing a group of multiple randomised participant
from a source, coded by colour. The recruitment strat-
egy engaged a range of MSM, but less so trans women.
Median age was 32.1 years (IQR 25.9, 41.6). Cis-gender
MSM comprised the majority (99%) of the sample, as
did participants of white ethnicity (89%, n = 921), and
MSM who identified as gay (89%, n = 757). Most (60%,
n = 611) were highly educated and reported CAI within
the preceding 3 months (70% n = 726). Sixty-four per-
cent of participants (n = 652) had tested for HIV in the
preceding year and 14% (n = 141) had never previously
tested. Of never tested participants, 82 (58%) reported
one or more CAI partners in preceding 3 months. Table
2 presents full details of baseline demographics.
There were significant differences in age (p < 0.001)
and gender (p = 0.01) across recruitment sources, with
all other variables being similar. As anticipated, Growlr
recruited older participants whereas Facebook recruited
younger ones. Free advertising targeted towards trans
people was most effective for reaching trans participants,
although numbers were small. See Table 2.
Motivations of participants (qualitative sub-study)
Table 3 presents demographic characteristics of the
qualitative sub-study. All participants were cis-MSM.
When discussing their motivations for joining SELPHI,
participants described three predominant motivations: i)
to access HIV testing; ii) desire to use a novel technol-
ogy; and iii) altruism.
Accessing testing
HIVST reduced specific HIV testing barriers, thereby fa-
cilitating uptake. This was especially true for those who
had never tested, and those who had not tested within
the preceding twelve months. Opportunity barriers (e.g.
convenience and ease of access) and motivational bar-
riers (e.g. confidentiality and stigma) were ameliorated
by HIVST.
Sometimes people ask you what you’re coming in for, [
… ] if you say, ‘oh I’m coming for an HIV [test]’ they
think you’re gay, or they think you’re disgusting, you
don’t use protection, or blah, blah, blah. But it’s
mainly about being labelled as something you’re not.
(23-year old bisexual man, never tested).
Desire to use a novel technology
Just under half of those interviewed reported being mo-
tivated to join SELPHI out of a desire to experience a
novel technology or because they felt SELPHI was a new
kind of study. HIVST was understood to be an evolution
of HIV testing methods which was appealing to some:
It’s an interesting one because it’s obviously very new.
So you kind of think, well it’s really great. [ … ] You
just think it’s something that’s interesting to try
because it’s new technology. (20-year old gay man,
tested in last 2 years).
Altruism
Altruistic motivations were reported by just over half of
participants with a range of testing histories. These were
predominantly secondary motivations, helping support
the decision to join a trial. Motivations were related to
notions of good citizenship, desire to contribute to the
gay community and to science more broadly.
I find it quite interesting actually that those kinds of
services are targeted towards people through Facebook
because you’re kind of transpiring an audience of people
who might benefit from that service. And I thought,
Table 1 Advertising source data
Recruitment source Facebook Growlr Hornet Grindr Free/organic Total
Number of campaigns 3 1 2 5 2 13
Advert clicks 1210 1193 Not available 6666 Not available Not available
Registered & eligible 216 120 590 406 38 1370
Registered & ineligible 32 19 109 144 9 313
Click conversion1 20% 12% Not available 8% Not available Not available
Randomised 173 96 433 308 27 1035
Registration conversion2 80% 80% 73% 76% 71% 76%
Spend per randomisation £3.70 £2.59 £1.66 £7.16 £0.00 £3.68
1Click conversion: proportion of clicks leading to a registration
2Registration conversion: proportion of eligible registrations leading to a randomisation
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“Actually that’s quite smart” because I’m in that
audience. And so, I just thought, “Yeah, I will give it a
try” (34-year old gay man, tested in last 3 months).
Kit use at two weeks and three months
Of 631 who were randomised to BT, 66% (415) com-
pleted a two-week follow-up survey. At this point, 95%
(394) reported having received their kit and 83% (328) of
those had used it themselves. Reasons for not using the
kit were mainly that participants were planning to use it
in the future (97% n = 64) or that participants had tested
elsewhere instead (3%).
At the three-month survey, completed by 64% of eligible
participants, 97% (390/403) reported having received, of
which 96% (375/390) had used the kit. This indicates that
although a significant minority delayed kit use, most did
use the test kit by three months.
When results from both surveys were pooled, provid-
ing data for 78% of participants, 97% (477/494) received
the kit and 90% (445/494) had used it. Assuming that all
those participants that did not complete either of these
surveys received the kit (137/ 631), but none used it,
then the lowest possible estimate of kit use was 71%
(445/631).
HIVST usability and acceptability
At three months, participants reported very high HIVST
usability and acceptability. Of 375 who used the kit and
completed the three-month survey, 98% (362/369) found
Table 2 Participant demographics by advert source and overall
Recruitment sources Facebook Growlr Hornet Grindr Free/organic Total p-values
Number of campaigns 1 2 5
N 173 96 431 308 27 1035
Median (IQR) age (years) 29.2 (24.6, 32.8) 44.8 (34.0, 51.2) 30.8 (24.7, 39.6) 35.0 (27.6, 45.4) 33.6 (29.2, 40.0) 32.1 (25.9, 41.6) p < 0.001
16–25 years 57 (33%) 7 (7%) 130 (30%) 60 (19%) 5 (19%) 259 (25%)
26–35 years 112 (65%) 23 (24%) 149 (35%) 102 (33%) 10 (37%) 396 (38%)
36–45 years 2 (1%) 22 (23%) 93 (22%) 72 (23%) 6 (22%) 195 (19%)
46 years or older 2 (1%) 44 (46%) 59 (14%) 74 (24%) 6 (22%) 185 (18%)
Gender identity P = 0.001
Cis man 171 (99%) 96 (100%) 430 (99%) 305 (99%) 23 (85%) 1025 (99%)
Trans man 1 (1%) 0 1 (1%) 2 (1%) 3 (11%) 8 (1%)
Trans woman 0 0 0 1 (< 1%) 1 (4%) 2 (< 1%)
Sexual Identity N = 153 N = 72 N = 361 N = 240 N = 25 N = 851 p = 0.23
Gay 143 (93%) 65 (90%) 322 (89%) 204 (85%) 23 (92%) 757 (89%)
Bisexual 8 (5%) 5 (7%) 35 (10%) 30 (13%) 1 (4%) 79 (9%)
Other 2 (1%) 2 (3%) 4 (1%) 6 (3%) 1 (4%) 15 (2%)
Ethnicity p = 0.52
White 153 (88%) 86 (90%) 394 (91%) 263 (85%) 25 (93%) 921 (89%)
Asian 5 (3%) 2 (2%) 13 (3%) 10 (3%) 1 (4%) 31 (3%)
Black 3 (2%) 3 (3%) 8 (2%) 12 (4%) 0 26 (3%)
Other 12 (7%) 5 (5%) 16 (4%) 23 (7%) 1 (4%) 23 (7%)
HEQ N = 172 N = 95 N = 425 N = 307 N = 27 N = 1026 P = 0.31
High 114 (66%) 59 (62%) 244 (57%) 174 (57%) 20 (74%) 611 (60%)
Medium 33 (19%) 16 (17%) 94 (22%) 65 (21%) 3 (11%) 211 (21%)
Low 25 (15%) 20 (21%) 87 (20%) 68 (22%) 4 (14%) 204 (20%)
HIV testing history N = 173 N = 96 N = 426 N = 304 N = 27 N = 1026 p = 0.09
Last 12 months 120 (69%) 54 (56%) 280 (66%) 185 (61%) 13 (48%) 652 (64%)
12months+ 39 (23%) 27 (28%) 85 (20%) 72 (24%) 10 (37%) 233 (23%)
Never 14 (8%) 15 (16%) 61 (14%) 47 (15%) 4 (15%) 141 (14%)
CAI last 3 months 124 (71%) 67 (70%) 308 (71%) 206 (67%) 21 (78%) 726 (70%) P = 0.58
IQR interquartile range, CAI condomless anal intercourse, HEQ highest educational qualification
Witzel et al. BMC Infectious Diseases          (2019) 19:699 Page 7 of 13
the instructions easy to understand, 97% (356/368)
found the test kit simple to use and 97% (359/369) re-
ported a good overall experience (Fig. 4).
All qualitative interview participants had used their
kits to test themselves. Below we describe intervention
acceptability as it relates to the main domains of COM-
B: capability, opportunity and motivation.
Capability (physical & psychological)
Capability was the most pronounced of the three
COM-B domains in our acceptability analysis, espe-
cially around test kit usability. Themes around phys-
ical capability tended to concern the instructions and
using the lancet to take a blood sample. The inclu-
sion of the two-week follow-up processes was a
Fig. 3 Map of randomised participants by recruitment source
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valued intervention element addressing psychological
capability.
The instructions were generally felt to be easy to
understand and interpret, although one participant felt
they did not cater to a sufficiently diverse range of skills.
The testing process was described as simple and the re-
sult was easy to interpret:
Very clear and it was quite obvious as well what goes
where and how to do it. It was clear. The descriptions
and the pictures were easy to follow (29 year-old man,
undisclosed sexual orientation, tested in last 5 years).
Blood collection via the included lancet was a barrier for
some. Those who had no previous experience of drawing
blood with a lancet reported concerns about their cap-
ability to collect their own sample, although all felt with
experience this would no longer be an issue.
I actually don’t like getting my finger pricked [ … ] so I
was most worried about the finger prick, [ … ] so for
me that was the most difficult thing, and then I wasn’t
sure if I was getting enough blood [ … ] but once I
pricked the finger and I collected the blood then it was
pretty straightforward (31-year old gay man, tested
last 4 weeks).
Capability (psychological) also emerged when discuss-
ing the support components of the intervention. Par-
ticipants generally felt that the supporting information
provided was adequate and did not diminish accept-
ability of the intervention.
What I think relieved me of most of the anxiety
was actually the kit included a card saying, at the
end, if you are diagnosed with HIV then not to
worry, here's what you can do. A, B, C. And if
you're not, great. A, B, C. And I think the steps on
that card saying, if you are, step one, step two, step
three, it helped to relieve some of the uncertainty of
what might happen if the test came out positive.
(16-year old gay man, not previously tested)
Opportunity (physical & social)
Themes related to acceptability of the entire inter-
vention package were primarily related to opportun-
ity (physical and social). For participants located in
areas underserved by HIV testing opportunities, the
kit ameliorated geographic barriers. Individuals who
faced psychosocial barriers to testing felt HIVST gave
them increased privacy around testing, enhancing the
acceptability of the intervention.
I’m quite a private person. I like to keep certain
aspects of my life to myself and sometimes people
might be bothering you to talk about things where you
think, “Well, I’m not there yet.” [ … ] Whereas I can
let that sink in and think, “Right, okay, now I’m ready
to go and do whatever I need to do or talk to whoever
I need to talk to.” (34 year-old gay man, tested more
than 12 months ago).
Motivation (reflective & automatic)
The dislocation of HIVST from care pathways affected
acceptability through motivational channels. Despite
high acceptability related to the follow-up provided,
HIVST as a concept was perceived to be associated
with increased anxiety relative to other testing oppor-
tunities. This was largely due to concerns about con-
ducting a test alone, and the potential separation of
initial “diagnosis” from established care pathways.
[ … ] I think slightly the kit at home [makes me more
anxious]. It’s almost because it’s literally taken out of
your hands when you go to an STI clinic. So you don’t
have to think about it as much. It’s something done to
you. (29-year-old gay man, tested within last 5 years)
Table 3 Qualitative sub-study sample
Demographic characteristics Sample
Age 18–25 years 3
26–40 years 6
41+ 1
Ethnicity White 8
Black 0
Asian 1
Other / Mixed 1
Sexual orientation Gay 8
Bisexual 1
Other / undisclosed 1
Recency of HIV testing < 12months 2
+ 12months 6
Never tested 2
HEQ Low 3
Medium 2
High 5
Condomless anal intercourse
preceding 3-months
0 1
1 6
2 2
3–10 1
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One participant delayed using the kit due to anxiety and
instead visited a GUM clinic, saving his HIVST for use
at a later date.
The 15min interval between conducting the test and
reading the result was described as an exceptionally anx-
ious time, especially for those who had tested due to risk.
I was feeling nervous actually because I was thinking
what about if it does come back positive. That was
quite like a bit of a head scratcher, waiting for the 15
minutes, and then when 15 minutes were up and I
looked at the result and I was like, oh, you know it
was negative so I thought right, but then I thought well
yeah, maybe I shouldn’t have worried that much, but
you can’t help it (23-year old bisexual man, not
previously tested).
All participants described significant relief when read-
ing a negative (non-reactive) result. A minority, who
had more experience of HIV testing, felt that HIVST
was associated with less anxiety than testing methods
relying on laboratory-run tests due to the relative im-
mediacy of results.
Discussion
Through this mixed methods study we assessed the feasi-
bility of recruiting MSM and trans people to the pilot
phase of the online SELPHI RCT and the acceptability of
HIVST, focusing mainly on the acceptability of the inter-
vention and the usability of the kit.
Advertising performance varied according to platform
by click and registration conversions and, crucially, cost.
The pilot sample was predominantly white, well-educated,
gay identified cis-MSM who reported CAI in the 3-
months preceding and who had tested for HIV in the pre-
ceding 12-months. The pilot struggled to recruit signifi-
cant numbers of trans people, particularly trans women.
Our recruitment did however, reach a range of partici-
pants across demographic groups. Platforms recruited
participants of a similar demographic and behavioural
profile except when considering age and gender identity.
Sixty-six percent of participants completed the two-
week follow-up, and 64% the three-month survey. Over-
all 78% of participants randomised to receive HIVST
completed at least one of the two. Kit use was high, in-
creasing from 86% at two-weeks to 96% at three months.
The lowest possible estimate of kit use was 71%, assum-
ing that all those not completing the follow-up surveys
did not use their kits, which is unlikely. The kit was con-
sidered usable and the intervention was acceptable
across the three dimensions interrogated (ease of use of
instructions, test simple to perform and overall experi-
ence). Qualitative data provides nuance, with some par-
ticipants reporting difficulty using the lancet. The
relationship between HIVST and anxiety was ambiguous;
individuals thought it could increase or ameliorate anx-
iety depending on previous HIV testing experience.
Fig. 4 Intervention acceptability
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Our recruitment strategy was successful in reaching a
group at risk of HIV who had not HIV tested previously,
with 58% of never tested MSM reporting CAI in the 3-
months preceding their enrolment. This is a key group
with clear HIV prevention needs who should be a pri-
mary target for new testing interventions. The sample
recruited in the pilot was comparable to previous con-
venience samples of MSM, as well as the ethnic make-
up of the UK [38, 39]. This indicates that this type of re-
cruitment strategy is capable of reaching a group broadly
representative of UK MSM in terms of ethnicity. A
group which is underrepresented when compared to na-
tional statistics is MSM of Asian ethnicity [39]. This
could be due to specific privacy barriers to a postal de-
livery HIVST service experienced by this group, outlined
in formative work [11]. Further, our sample reported
similar levels of never testing (14%) to other convenience
samples of UK MSM (other recent samples range be-
tween 8 and 25%), although more participants in the
SELPHI pilot had tested in the preceding 12months
[38].
When compared to HIVSS return rates in the UK, par-
ticipants in the pilot made use of their HIVST kits more
frequently, lessening missed opportunities for testing.
While with HIVSS only 55% of samples are returned for
processing [14, 15], 95% reporting kit use at three
months and at least 71% of kits were used overall. At
this modest scale, HIVST appears to outperform HIVSS.
Acceptability and ease of use was very high, and in-
deed higher than in many other studies with MSM [8].
This is not without precedent, with similar levels of ac-
ceptability and reported ease of use observed in other
settings [13, 40, 41]. These studies however provided
oral fluid HIVSTs, which may have benefits in terms of
simplicity (though have lower sensitivity and specificity)
over kits which require self-collection of a whole blood
sample [8, 42].
Qualitative accounts of acceptability focused on COM-
B domains related to capability more than opportunity
or motivation [20]. This could signify that when en-
gaging with this novel testing technology, individuals are
often doing so with questions about their own skills and
capacity. These concerns may decrease with increased
experience with HIVST. Indeed, using the lancet was de-
scribed as difficult for many, although they managed to
use it successfully despite this, and all expected this
would improve with experience. An additional focus of
enquiry for future study is the experience of those who
have reactive tests (both confirmed as positive and sub-
sequently confirmed negative) to better understand their
experiences, support needs and any potential harms
arising.
A number of changes to the trial design were made as a
result of this pilot. The attrition between registration and
enrolment surveys (24% of participants overall) posed sig-
nificant recruitment challenges. For the main roll-out of
the RCT the language in the email linking the two surveys
was made more motivational, specifically highlighting al-
truism. In addition, all messages used in the roll-out were
designed to more clearly emphasise trans eligibility. In re-
sponse to the increased costs generated by attrition and to
take advantage of advertising efficiencies at larger scales,
national rather than regional advertising campaigns were
prioritised to increase recruitment volumes. Advertise-
ment messages were also altered, with increasing use of
motivational elements. In efforts to increase survey com-
pletion rates, the number of reminders was increased from
2 to 3, and delivery times were staggered at different times
of the day to account for a variety of employment pat-
terns. These changes were supported by a PPI engagement
exercise with SELPHI participants.
Strengths and limitations
This is the first study in Europe to assess the feasibility of
recruiting to an online HIVST RCT. A strength of this
pilot is that the design perfectly mimics the full trial.
Nevertheless, some limitations are noted. Recruited costs
per participant should be treated with some caution. For
one, the possibility of being randomised to the no baseline
HIVST/SoC arm likely made costs per participant signifi-
cantly higher than delivering free HIVST to all. In
addition, recruitment costs in this pilot phase did not
show evidence of diminishing returns per participant ran-
domised, meaning that overall cost per participant could
become much higher when recruiting larger numbers.
Test kit usability and intervention acceptability were
extremely high when compared to other recent studies
[8]. A possible explanation is the informed consent pro-
cedures in place provided a great deal of information
about what a participant could expect from the study
and the kit itself in a level of detail that a service might
not include.
This pilot struggled to recruit large numbers of trans
people compared with cis gender MSM. In addition, sex-
ual practice among MSM is diverse. As only MSM who
report lifetime anal sex were eligible for inclusion our
sample may not be fully representative of the diversity in
MSM sexual behaviour, as between 8 and 19% have
never had anal sex [43–45]. This issue may be an espe-
cially pronounced for trans MSM and may have contrib-
uted to the low numbers of trans people recruited in
this pilot phase.
Finally, while the qualitative data is illuminative, inter-
view were conducted with a small group of participants.
The data presented here should be understood as
highlighting the diversity of facets of kit usability and
intervention acceptability.
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Conclusion
Recruiting to this online HIVST pilot RCT was feasible, the
intervention was acceptable to participants, and the kit dis-
tributed had high reported usability. Kit use was high, out-
performing previous HIVSS projects in the UK. This pilot
led to a number of changes to the implementation of the
RCT, including national advertising and enhancing efforts
to boost trial retention. Further research investigating the
experiences of trans people is necessary in order to opti-
mise future intervention approaches for this group.
Additional files
Additional file 1: Kit sleeve design. (JPG 519 kb)
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